KILITCH DRUGS (INDIA)
Back to Cashflow Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹8.81 Cr | ₹-0.72 Cr | ₹7.03 Cr | ₹1.61 Cr | ₹0.85 Cr |
What is the latest Cash Flow from Financing Activities ratio of KILITCH DRUGS (INDIA) ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹8.81 Cr |
Mar2023 | ₹-0.72 Cr |
Mar2022 | ₹7.03 Cr |
Mar2021 | ₹1.61 Cr |
Mar2020 | ₹0.85 Cr |
How is Cash Flow from Financing Activities of KILITCH DRUGS (INDIA) Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹8.81 Cr | Positive | |
Mar2023 | ₹-0.72 Cr | Negative | |
Mar2022 | ₹7.03 Cr | 335.44 | |
Mar2021 | ₹1.61 Cr | 89.88 | |
Mar2020 | ₹0.85 Cr | - |
Compare Cash Flow from Financing Activities of peers of KILITCH DRUGS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KILITCH DRUGS (INDIA) | ₹543.1 Cr | -6.7% | 8% | -8.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,142.0 Cr | -1.5% | 9.1% | 9.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,762.0 Cr | -4.9% | -0.6% | 59.1% | Stock Analytics | |
CIPLA | ₹114,322.0 Cr | -1.8% | 1% | 0.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,171.0 Cr | 1.6% | 12.1% | 21.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,603.7 Cr | -3% | -0.9% | -7.7% | Stock Analytics |
KILITCH DRUGS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KILITCH DRUGS (INDIA) | -6.7% |
8% |
-8.5% |
SENSEX | -2.9% |
3.1% |
1.8% |
You may also like the below Video Courses